R&D INNOVATION

Technological innovation —

Chemical Active Pharmaceutical Ingredients

Detailed introduction

Number

Product Name

Application

Technical or regulatory status

1

Marboxilav

Influenza virus infection

Process Validation

2

Ruxolitinib phosphate

Myelofibrosis

Process Validation

3

Litaist

Dry Eye Syndrome

Pilot testing

4

Bromodiglycine

Myasthenia Gravis

Process Validation

5

Bulixitan

Epilepsy

Process Validation

6

Benidipine Hydrochloride

Primary hypertension, angina pectoris

Already declared

7

Kainivatan

Hyponatremia

Already declared

8

Sugammadex Sodium

Muscle relaxant antagonist

Already declared

9

Linezolid

Infections caused by specific microbial-sensitive strains

CXHL1300397

10

Polyprill Zinc

Stomach ulcer

National Medical Product Approval Number H20120090

11

Clopidogrel bisulfate

Platelet inhibitor

CYHS1201638

12

Cinepazide Maleate

Acute ischemic stroke

CYHS1100004

13

Fasudil Hydrochloride

Vascular spasm

CYHS1100006

14

Sulfobutyl beta-cyclodextrin sodium

Pharmaceutical excipients

Already declared

Note: Products protected by patents are intended solely for research and development purposes.

Keywords: